The Pfizer Sites Master Plan addresses the rezoning of several superblock sites in Williamsburg, Brooklyn. MAP’s plan responds to the scale of the neighborhood, the need for affordable housing. The design creates a generous, safe, green, pedestrian corridor breaking up the potential super block sites. The corridor allows for car-free access to retail at the ground floor of the mixed use buildings and includes 25 trees with planters, Benches, 40 tables and chairs and 12 bike racks.
The Rabsky Group’s new Pfizer site-replacing residential project received the support of the local community board, a major step in making this project a reality on June 13th 2017.
History of the Sites:
1849: Former Owner: Pfizer Corporation established.
1989: Pfizer stopped producing pharmaceuticals in Brooklyn.
1989: Broadway Triangle Urban Renewal Plan approved.
2009: Property removed from Urban Renewal Area.
2011: Pfizer offered land for sale.
2012: Harrison Realty LLC purchased site.
The Proposed Project Massing includes:
• 8 buildings
• 1,146 dwelling units
• 287 affordable units
• Up to 62,810 sf retail
• Approximately 404 parking spaces